Research Article
Cardiometabolic Risk in Hyperlipidemic Men and Women
Table 2
Characteristics of the study sample with prediabetes, divided by sex.
| | (female/male) | Female | Male | value |
| Age [years] | 19/29 | | | 0.007 | Body weight | 19/28 | | | <0.001 | BMI [kg/m2] | 19/28 | | | 0.360 | Waist [cm] | 18/27 | | | 0.001 | RRS [mmHg] | 14/20 | | | 0.164 | RRD [mmHg] | 14/20 | | | 0.223 | TC [mg/dL] | 19/29 | | | 0.371 | LDL-C [mg/dL] | 18/27 | | | 0.746 | HDL-C [mg/dL] | 17/27 | | | <0.001 | NHDL-C [mg/dL] | 17/27 | | | 0.640 | ln(TG) [mg/dL] | 19/29 | | | 0.165 | ln(TG/HDL) | 17/27 | | | 0.003 | ln(Lip.a) [units] | 17/26 | | | 0.013 | IMT-left [mm] | 17/26 | | | 0.576 | IMT-right [mm] | 17/26 | | | 0.463 | IMT av [mm] | 17/26 | | | 0.834 | Glucose [mg/dL] | 19/27 | | | 0.882 | ln(insulin+1) [μU/mL] | 17/27 | | | 0.273 | C-peptide [ng/mL] | 16/23 | | | 0.656 | HbA1c [%] | 19/28 | | | 0.322 | QUICKI-test | 16/23 | | | 0.478 | ln(proBNP) [units] | 16/23 | | | 0.905 | ln(hsCRP+1) [units] | 17/28 | | | 0.440 | ln(GOT) [mg/dL] | 18/29 | | | 0.499 | ln(GPT) [mg/dL] | 18/29 | | | 0.098 | ln(GGT) [mg/dL] | 18/29 | | | 0.048 | Ezetimibe | 19/23 | 2 (10.5) | 3 (13.0) | 1.000 | Nicotinic acid | 19/23 | 0 (0.0) | 2 (8.7) | 0.556 | Fibrates | 19/23 | 2 (10.5) | 9 (39.1) | 0.081 | Statins | 19/23 | 11 (57.9) | 19 (82.6) | 0.155 | CVD | 18/27 | 1 (5.6) | 8 (29.6) | 0.110 | Mean steps 7 days | 17/21 | | | 0.114 | Metabolic syndrome | 12/20 | 5 (41.7) | 12 (60.0) | 0.522 | Mean treatment duration of the last taken dyslipidemic medication (days) | 18/28 | | | 0.938 |
|
|
-test, Chi-square test. Data are presented as number of observations () and means ± standard deviation. BMI (body mass index), waist (waist circumference), RRS (systolic blood pressure), RRD (diastolic blood pressure), TC (total cholesterol), LDL-C (low density lipoprotein cholesterol), HDL-C (high density lipoprotein cholesterol), NHDL-C (non-high density lipoprotein cholesterol), TG (triglycerides), TG/HDL (triglyceride/HDL-cholesterol ratio), Lip.a (lipoprotein (a)), IMT (carotid intima media thickness), HbA1c (glycated hemoglobin A1c), QUICKI (quantitative insulin sensitivity check index), proBNP (pro B-type natriuretic peptide), hsCRP (high sensitive C-reactive protein), GOT (glutamate-oxaloacetate transaminase), GPT (glutamate-pyruvate transaminase), GGT (gamma-glutamyl transferase), and CVD (cardiovascular disease).
|